NTRA

NASDAQ · Biotechnology

Natera Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$194.24

-25.58 (-11.64%)

As of May 10, 9:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 25 89%

Hold 3 11%

Sell 0 0%

Price Target

Analyst Price Target -26.4% upside

Low Target $88.14

Average Target $142.91

High Target $188.78

Current Price $194.24

Current
$194.24

Target
$142.91

$88.14 $142.91 avg $188.78

Scenario Analysis

Bear Case

$88.14

-54.6%

Low target

Base Case

$142.91

-26.4%

Avg target

Bull Case

$188.78

+-2.8%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$256.36

-24.2% from high

52-Week Low

$131.81

+47.4% from low

50-Day SMA

$229.31

-15.3% vs SMA

200-Day SMA

$186.42

+4.2% vs SMA

RSI (14)

38.6

Neutral

Target vs 52W High

$142.91

-44.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%